|
"hwu cm"的相關文件
顯示項目 86-95 / 125 (共13頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2020-06-23 |
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
|
Yen, FS;Hsu, CC;Li, HL;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2020-06-22 |
Persons with type 2 diabetes and high insulin persistence were associated with lower risk of mortality: A nationwide retrospective cohort study
|
Yen, FS;Wei, JC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2020-05-04 |
Urate-lowering therapy exerts protective effects against hypertension development in patients with gout
|
Lin, KH;Yen, FS;Li, HL;Wei, JCC;Hsu, CC;Yang, CC;Hwu, CM |
| 國家衛生研究院 |
2020-02-27 |
Urate-lowering therapy may prevent the development of coronary artery disease in patients with gout
|
Yen, FS;Hsu, CC;Li, HL;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2020-01-21 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS;Yang, YC;Hwu, CM;Wei, JC;Huang, YH;Hou, MC;Hsu, CC |
| 中山醫學大學 |
2020 |
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
|
Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2020 |
The factors associated with insulin nonpersistence in persons with type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS; Yang, YC; Hwu, CM; Wei, JCC; Huang, YH; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2020 |
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2020 |
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus
|
Yen, FS; Wang, HC; Pan, CW; Wei, JCC; Hsu, CC; Hwu, CM |
顯示項目 86-95 / 125 (共13頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
|
